Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: An 8-year longitudinal study
Rong Ye, Joseph J. Locascio, Anna E. Goodheart, Moqing Quan, Baorong Zhang, Stephen N. Gomperts
Topics & Concepts
Dopamine transporterParkinson's diseaseInternal medicinePutamenBiomarkerDopamineMontreal Cognitive AssessmentLevodopaMedicineEndocrinologyPsychologyOncologyDiseaseDementiaDopaminergicBiologyBiochemistryParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsBotulinum Toxin and Related Neurological Disorders